 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.

Slides:



Advertisements
Similar presentations
The PARticulars of Parkinson’s Disease
Advertisements

Neurological Diseases/Injuries/Disorders What can you do to protect your nervous system?
What can you do to protect your nervous system?. Epilepsy Most common neurological disorder in US Seizure disorder(must have 2 or more)—electrical impulses.
An Overview of Conventional and Experimental Treatments
ABC’s of Parkinson’s Disease 4/29/15 Karen Parenti, MS, PsyD.
Movement part 2. Cerebellum and Brainstem KW p. 363.
Parkinson’s Disease Historical Perspective  First described by British doctor James Parkinson  Identified its major symptoms and called it “the shaking.
Parkinson’s disease Interventions Whitney Mundy Dr. Davis.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
Is it a neurodegenerative brain disorder that progresses slowly in most people.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Deep Brain Stimulation For parkinson’s disease
Alzheimer’s Disease What YOU need to know about it! You could be the 1 out of 8 who have Alzheimer’s Disease.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Chapter 20 Human Nervous System Regulation Is achieved by both the nervous system and the endocrine system in humans *Both systems secrete chemicals.
Parkinson’s Disease By Devin Cornford
Parkinson's Disease Katherine Patetta March 6, 2013 Period 1.
Monday 20 th July 2009 Parkinson’s Summerschool A Personal Perspective On Parkinson’s Tom Isaacs Co-Founder – Cure Parkinson’s Trust Board Member – European.
Huntington Disease Genetic Disorder Project Alaukika Desai AP Biology Period 3.
LOU GEHRIG’S DISEASE.  Also known as Amyotrophic Lateral Sclerosis  Is a disease of the nerve cells in the brain and spinal cord that control voluntary.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
BY: MACKENZIE SOARES ALYSSA MEDIEROS STEPHANIE GARDNER Parkinson's Disease.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
MULTIPLE SCLEROSIS UNUSUAL SENSATIONS BLADDER PROBLEMS TROUBLE WALKING DIZZINESS FATIGUE MUSCLE SPASMS SEXUAL TROUBLE SPEECH PROBLEMS THINKING PROBLEMS.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Parkinson’s Disease. 1817: Dr. James Parkinson: What is Parkinson’s Disease?
PARKINSON’S DISEASE By: AARUSHI JAIN AMRUTA KAMBLE ANNETT MARY JACOB AVANTI DEO M.Sc. PRIST (09-11)
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
Sarah Ehlers & Brendan Valentine Parkinson’s Disease.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
Parkinson's disease Carlo Varas. Definition progressive disorder of the nervous system that affects movement. tremor may be the most well-known sign of.
By: Alejandro Navarro and Andrea Ors. Content Introduction What is Parkinson's disease? What causes the disease? History Main symptoms Treatment Statistics.
Neurological Disorders
Amyotrophic Lateral Sclerosis (ALS)
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
By Katelyn Chaimson and Sean Guyot
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Hannah Beacom and Thomas Bennett Pd. 3.  Rare inherited disorder  Caused by genetic stutter  Progressive loss of nerve cells in brain  Results in.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
 Parkinson Disease (PD) is a progressive disorder of the central nervous system that often impairs the sufferer's motor skills, speech, and other functions.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
By Seamus Hogan.  Parkinsons disease is degenerative disorder of the central nervous system. it causes the dopamine to contain cells in the substantial.
Parkinson’s Disease Casey Wang
Neurotransmitters in the brain By Joon Kim. Neurotransmitters  A neurotransmitter is a specialized messenger chemical that transfers or sends information.
PARKINSON’S ADAM KREAMER. WHAT IS PARKINSON’S? *Parkinson’s disease, also called PD, is categorized as a motor system disorder, which is a result of the.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
PARKINSON’S DISEASE LUKE CARROLL & LAUREN DESROCHES.
Understanding Parkinsons Disease
Module 7.3 Movement Disorders
Parkinson’s Disease Celsey and Chylee.
Falon Fiorillo & Breeanna Fournier
Parkinson's disease KRZYSZTOF NICPOŃ.
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
ANTIPARKINSONS Drugs By Dr. Mirza Shahed Baig.
N EW S TUDY : P ARKINSON ’ S DISEASES MAY START IN THE STOMACH Parkinson’s disease is a progressive nervous system disorder and the symptoms of the Parkinson’s.
Parkinson’s Disease By: Megan Muth Period 3.
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

 Parkinson Disease (PD) is a disorder of the brain that causes a variety of movement problems.

 The causes of Parkinson Disease remains unknown.  Many experts think that the disease is caused by a combination of genetic and environmental factors.  Scientists have identified aging as an important cause.

 About 15 to 25 percent of people with Parkinsons report having a relative with the disease.  Researchers have discovered several gene mutations that can cause the disease directly, but these affect only a small number of families.

 Some scientists have suggested that Parkinson's disease may result from exposure to an environmental toxin or injury.  Researchers have identified several factors that may be linked to Parkinson’s.  rural living  well water  manganese  pesticides  Some studies have demonstrated that prolonged occupational exposure to certain chemicals can be a trigger as well.

 A substance called dopamine acts as a messenger between two brain areas, the substantia nigra and the corpus striatum to produce smooth, controlled movements.  When the amount of dopamine is too low, communication between the substantia nigra and corpus striatum becomes ineffective, and movement becomes impaired.  The greater the loss of dopamine, the worse the movement-related symptoms

 Parkinson's disease is the second most common neurodegenerative disorder.  The most common movement disorder.  In the United States, about 1 million people are affected by Parkinson's disease and worldwide about 5 million.

Primary symptoms include: tremor, stiffness, slowness, impaired balance shuffling

 Effects the present areas

 Anxiety, insecurity, and stress  Confusion and memory loss  Constipation  Depression  Difficulty swallowing and excessive salivation  Increased sweating  Skin problem  Slowed, quieter speech, and monotone voice  Urinary frequency/urgency

 Most people who develop Parkinson's disease are older than 60 years of age.  Men are affected about 1.5 to 2 times more often than women.  People who have a family history of the disorder.  Exposure to environmental toxins such as pesticides and herbicides may be a risk factor.

 There is currently NO treatment to cure Parkinson's disease.

 For some individuals with unmanageable motor symptoms, surgery may be an option.  In deep brain stimulation(DBS), the surgeon implants electrodes to stimulate areas of the brain involved in movement.  In another type of surgery, specific areas in the brain that cause Parkinson's symptoms are destroyed.  An alternative approach currently being explored is the use of dopamine-producing cells derived from stem cells.

 General lifestyle changes (rest and exercise), physical therapy, occupational therapy, and speech therapy may be beneficial.

 Parkinson’s Disease is NOT preventable.

 The severity of Parkinson's disease symptoms vary greatly from individual to individual and it is not possible to predict how quickly the disorder will progress.  Parkinson's disease is not a fatal disease, and the average life expectancy is similar to that of people without the disease.

  Ogody0m7XA Ogody0m7XA  Disease/Parkinson-s-Symptoms.aspx?s_mcid=google-ppc- &s_kwcid=TC|6774|parkinsons%20disease%20symptoms||S|| &gclid=CJGPtMWr868CFYeo4AodehfvXA Disease/Parkinson-s-Symptoms.aspx?s_mcid=google-ppc- &s_kwcid=TC|6774|parkinsons%20disease%20symptoms||S|| &gclid=CJGPtMWr868CFYeo4AodehfvXA 